These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30942668)

  • 1. Measles on the March: A Call to Action.
    Woodland DL
    Viral Immunol; 2019 May; 32(4):160. PubMed ID: 30942668
    [No Abstract]   [Full Text] [Related]  

  • 2. The Clinical Impact and Cost-effectiveness of Measles-Mumps-Rubella Vaccination to Prevent Measles Importations Among International Travelers From the United States.
    Hyle EP; Fields NF; Fiebelkorn AP; Walker AT; Gastañaduy P; Rao SR; Ryan ET; LaRocque RC; Walensky RP
    Clin Infect Dis; 2019 Jul; 69(2):306-315. PubMed ID: 30312374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles returns to the Gaza Strip.
    Bagcchi S
    Lancet Infect Dis; 2020 Mar; 20(3):291. PubMed ID: 32112765
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccine Refusal and Measles Outbreaks in the US.
    Phadke VK; Bednarczyk RA; Omer SB
    JAMA; 2020 Oct; 324(13):1344-1345. PubMed ID: 32797149
    [No Abstract]   [Full Text] [Related]  

  • 5. US measles outbreak concentrated among unvaccinated children.
    Nelson R
    Lancet Infect Dis; 2019 Mar; 19(3):248. PubMed ID: 30833064
    [No Abstract]   [Full Text] [Related]  

  • 6. Approach to verify the status of measles, rubella, and congenital rubella syndrome elimination in Costa Rica.
    Morice A; Avila-Aguero ML; Salas-Peraza D; Soriano A; Castillo-Solórzano C
    J Infect Dis; 2011 Sep; 204 Suppl 2():S690-7. PubMed ID: 21954268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles epidemic in Brazil in the post-elimination period: Coordinated response and containment strategies.
    Lemos DR; Franco AR; de Sá Roriz ML; Carneiro AK; de Oliveira Garcia MH; de Souza FL; Duron Andino R; de Góes Cavalcanti LP
    Vaccine; 2017 Mar; 35(13):1721-1728. PubMed ID: 28256359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curbing the 2019 Samoa measles outbreak.
    Champredon D; Shoukat A; Singer BH; Galvani AP; Moghadas SM
    Lancet Infect Dis; 2020 Mar; 20(3):287-288. PubMed ID: 32112762
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing Immunosuppressed Patients With Inflammatory Bowel Disease During a Measles Outbreak.
    Cohen ER; Salem M; Ha C
    Am J Gastroenterol; 2019 Oct; 114(10):1563-1565. PubMed ID: 31498155
    [No Abstract]   [Full Text] [Related]  

  • 10. Measles Outbreaks in US and Abroad Prompt CDC Vaccination Alert.
    Harris E
    JAMA; 2024 May; 331(17):1439. PubMed ID: 38607648
    [No Abstract]   [Full Text] [Related]  

  • 11. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Largest Measles Outbreak, Including 38 Modified Measles and 22 Typical Measles Cases in Its Elimination Era in Yamagata, Japan, 2017.
    Komabayashi K; Seto J; Tanaka S; Suzuki Y; Ikeda T; Onuki N; Yamada K; Ahiko T; Ishikawa H; Mizuta K
    Jpn J Infect Dis; 2018 Nov; 71(6):413-418. PubMed ID: 29962488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in Measles Cases - United States, January 1-April 26, 2019.
    Patel M; Lee AD; Redd SB; Clemmons NS; McNall RJ; Cohn AC; Gastañaduy PA
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):402-404. PubMed ID: 31048672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
    Singh HK; Chiu YL; Wilkin T
    AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909
    [No Abstract]   [Full Text] [Related]  

  • 17. International Importations of Measles Virus into the United States During the Postelimination Era, 2001-2016.
    Lee AD; Clemmons NS; Patel M; Gastañaduy PA
    J Infect Dis; 2019 Apr; 219(10):1616-1623. PubMed ID: 30535027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles outbreak in Venezuela: a new challenge to postelimination surveillance and control?
    Sarmiento H; Cobo OB; Morice A; Zapata R; Benitez MV; Castillo-Solórzano C
    J Infect Dis; 2011 Sep; 204 Suppl 2():S675-82. PubMed ID: 21954266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies.
    Edmunds WJ; Gay NJ; Kretzschmar M; Pebody RG; Wachmann H;
    Epidemiol Infect; 2000 Dec; 125(3):635-50. PubMed ID: 11218214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.